Association between psoriasis and coronary calcium score
Carregando...
Citações na Scopus
39
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Citação
ATHEROSCLEROSIS, v.237, n.2, p.847-852, 2014
Resumo
Background: Emerging data suggests that chronic inflammatory disease, such as psoriasis, may be associated to coronary artery disease (CAD). Objective: Analyze the association between psoriasis and subclinical atherosclerosis using coronary calcium score (CAC). Methods: We investigated 221 participants with psoriasis and 718 age-and sex-matched controls without prior known CAD. All participants completed a questionnaire and underwent laboratory tests and a CAC exam. Logistic regression models adjusted for Framingham risk score (FRS) and C-reactive protein (hs-CRP) were built. CAC was included in the models as a binary variable with different cut off values. Results: Body-mass index, race, hypertension, HDL, LDL and hs-CRP were significantly associated with psoriasis presence and severity. Psoriasis severity was significantly associated with CAC (p = 0.04), particularly for very high CAC (>400) (p <0.01). The OR for severe psoriasis and CAC >400 was 2.45 (95%CI: 1.26-4.75) in unadjusted models. In a model adjusted for the FRS, this association was no longer significant, but a trend was noted (p = 0.09). No significant changes in the association were noted after the inclusion of hs-CRP in the model. Conclusion: Psoriasis is associated with higher CAC values, mainly in individuals with severe psoriasis. The current findings also suggest the potential involvement of other mechanisms beyond classical cardiovascular risk factors and inflammation in this association.
Palavras-chave
Coronary artery calcium, Cardiovascular disease, Cardiovascular risk factors, Psoriasis, Subclinical atherosclerosis
Referências
- AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827
- Antonucci V.A., 2012, J EUR ACAD DERMATOL, V28, P512
- Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
- Armstrong AW, 2012, AM J CARDIOL, V109, P976, DOI 10.1016/j.amjcard.2011.11.025
- Armstrong AW, 2013, J HYPERTENS, V31, P433, DOI 10.1097/HJH.0b013e32835bcce1
- Atzeni F, 2011, J RHEUMATOL, V38, P1661, DOI 10.3899/jrheum.100893
- Balci D.D., 2009, EUR ACAD DERMATOL VE, V23, P1
- Coto-Segura P., 2013, BR J DERMATOL, V91
- Dowlatshahi EA, 2013, J INVEST DERMATOL, V133, P2347, DOI 10.1038/jid.2013.131
- Dowlatshahi E.A., 2013, BR J DERMATOL, V168
- Eder L., 2013, ANN RHEUM DIS, V73, P1990
- Eder L, 2008, J RHEUMATOL, V35, P877
- Enany B., 2012, HERZ, V5, P527
- Finlay AY, 2005, BRIT J DERMATOL, V152, P861, DOI 10.1111/j.1365-2133.2005.06502.x
- Gaeta M., 2013, INT J CARDIOL
- Gelfand JM, 2005, ARCH DERMATOL, V141, P1537, DOI 10.1001/archderm.141.12.1537
- Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735
- Gonzalez-Juanatey C, 2007, ARTHRIT RHEUM-ARTHR, V57, P1074, DOI 10.1002/art.22884
- Kaul M.S., 2012, ARTHRIT CARE RES, V65, P266
- Kimhi O., 2007, ARTHRITIS RHEUM, V36, P203
- Kurd SK, 2009, J AM ACAD DERMATOL, V60, P218, DOI 10.1016/j.jaad.2008.09.022
- Ludwig RJ, 2007, BRIT J DERMATOL, V156, P271, DOI 10.1111/j.1365-2133.2006.07562.x
- Mehta NN, 2010, EUR HEART J, V31, P1000, DOI 10.1093/eurheartj/ehp567
- Patel RV, 2011, J GEN INTERN MED, V26, P1036, DOI 10.1007/s11606-011-1698-5
- Pitzalis C, 1998, BRIT J RHEUMATOL, V37, P480
- Tam LS, 2008, ARTHRIT RHEUM-ARTHR, V59, P1322, DOI 10.1002/art.24014
- The Centers for Disease Control and Prevention, 2004, NAT HLTH NUTR EX SUR
- Troitzsch P, 2012, ATHEROSCLEROSIS, V225, P486, DOI 10.1016/j.atherosclerosis.2012.09.026
- Warrington KJ, 2005, ARTHRITIS RES THER, V7, pR984, DOI 10.1186/ar1775
- Wilson PWF, 1998, CIRCULATION, V97, P1837
- Yiu KH, 2013, J INTERN MED, V273, P273, DOI 10.1111/joim.12002